STAT3 and neoplasm: Gemcitabine (GEM) is a chemotherapeutic drug that inhibits MDSCs through the selective blockage of the JAK/STAT3 pathway, responsible for their formation, inhibiting the immunosuppressive effects in the tumor microenvironment [137,180,181].